Partnership to Improve Population Health, Chronic Disease Management
Health IT Analytics January 5, 2022
The American Diabetes Association and Renalytix will collaborate to improve population health and chronic disease management for patients with type 2 diabetes.
To improve population health and chronic disease management, the American Diabetes Association and Renalytix have announced a joint program to enhance the overall kidney health of patients with type 2 diabetes in the United States.
Approximately 34.2 million Americans and an estimated 422 million people worldwide have diabetes. Type 2 diabetes is the most common type, making up 90 to 95 percent of all diabetes cases in adults.
Additionally, medical professionals now recognize kidney disease as a public health epidemic, impacting over 850 million individuals globally.